Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: PCSK9 inhibitors for secondary prevention in patients with cardiovascular diseases: a bayesian network meta-analysis

Fig. 3

Network analysis for secondary efficacy outcomes. A The forest plot for cardiovascular death. B The SUCRA value of each treatment for cardiovascular death. C The forest plot for myocardial infarction. D The SUCRA value of each treatment for myocardial infarction. E The forest plot for stroke. F The SUCRA value of each treatment for stroke. CrI credible interval, SUCRA surface under the cumulative ranking curve

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840